Martina Guerrero

Publicacions destacades

• Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?

  Autors:

  Crisafulli E; Guerrero M; Chetta A; Torres A ;

  Referència: EUROPEAN RESPIRATORY JOURNAL.

• DECIPHERING THE IMPACT OF IDELALISIB ON FOLLICULAR LYMPHOMA AND ITS IMMUNE MICROENVIRONMENT

  Autors:

  Matas-Cespedes, A.; Guerrero, M.; Magnano, L.; Grosmaire, L.; Yahiaoui, A.;

  Tannheimer, S.; Lopez-Guillermo, A.; Perez-Galan, P.;.

  Referència: HAEMATOLOGICA.

• Blood ammonia and lactate as markers of muscle metabolites during leg press exercise

  Autors:

  Gorostiaga, Esteban M; Navarro-Amezqueta, Ion; Calbet, Jose A L; Sanchez-Medina, Luis; Cusso, Roser;

  Guerrero, Mario; Granados, Cristina; Gonzalez-Izal, Miriam; Ibanez, Javier; Izquierdo, Mikel.

  Referència: JOURNAL OF STRENGTH AND CONDITIONING RESEARCH.

• Upregulation of heart PFK-2/FBPase-2 isozyme in skeletal muscle after persistent contraction

  Autors:

  Rovira, Jordi; Maria Irimia, Jose; Guerrero, Mario; Aureli Cadefau, Joan; Cusso, Roser;

  Referència: PFLUGERS ARCHIV EUROPEAN JOURNAL OF PHYSIOLOGY.

• Hexokinase 2, Glycogen Synthase and Phosphorylase Play a Key Role in Muscle Glycogen Supercompensation

  Autors:

  Irimia, Jose M; Rovira, Jordi; Nielsen, Jakob N; Guerrero, Mario; Wojtaszewski, Jorgen F P;

  Cusso, Roser.

  Referència: PLOS ONE.

• Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study

  Autors:

  Guerrero M; Crisafulli E; Liapikou A; Huerta A; Gabarrús A;

  Chetta A; Soler N; Torres A .

  Referència: PLOS ONE 2016.

• Predicting In-Hospital Treatment Failure (</=7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids

  Autors:

  Crisafulli E; Torres A; Huerta A; Guerrero M; Gabarrús A;

  (...)

  Martinez R; Soler N; Fernández L; Wedzicha JA; Menéndez R .

  Veure llistat complet d'autors

  Referència: COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2016.

• Identification of lysosomal Npc1-Binding Proteins: Cathepsin D activity is regulated by NPC1

  Autors:

  Macías-Vidal J; Guerrero-Hernández M; Estanyol JM; Aguado C; Knecht E;

  Coll MJ; Bachs O .

  Referència: PROTEOMICS 2016.

• C-Reactive Protein at Discharge, Diabetes Mellitus and >= 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  Autors:

  Crisafulli, Ernesto; Torres, Antoni; Huerta, Arturo; Mendez, Raul; Guerrero, Monica;

  Martinez, Raquel; Liapikou, Adamantia; Soler, Nestor; Sethi, Sanjay; Menendez, Rosario;.

  Referència: COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2015.

• The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations

  Autors:

  Macias-Vidal, J; Giros, M; Guerrero, M; Gascon, P; Serratosa, J;

  Bachs, O; Coll, AJ.

  Referència: Febs Journal 2014.